The first public molecular recognition database, BindingDB supports research, education and practice in drug discovery, pharmacology and related fields.

BindingDB contains 3.2M data for 1.4M Compounds and 11.4K Targets. Of those, 1.6M data for 756K Compounds and 4.8K Targets were curated by BindingDB curators. BindingDB is a FAIRsharing resource.

If BindingDB was of value to your research, please take a moment to donate to this nonprofit project. Your donation will let us provide you with more data and improved service.

To help with training and testing AI and other models, BindingDB downloads and search results now provide the publication date and BindingDB curation date of each measurement.

9 articles for T Kobrlova


The following articles (labelled with PubMed ID or TBD) are for your review

PMID
Data
Article Title
Organization
Development of submicromolar 17β-HSD10 inhibitors and their in vitro and in vivo evaluation.EBI
University of Hradec Kralove
Novel DEBI
Czech Republic
7-Azaindole, 2,7-diazaindole, and 1H-pyrazole as core structures for novel anticancer agents with potential chemosensitizing properties.EBI
University Hospital Hradec Kralove
2-Propargylamino-naphthoquinone derivatives as multipotent agents for the treatment of Alzheimer's disease.EBI
University Hospital Hradec Kralove
Discovery of novel berberine derivatives with balanced cholinesterase and prolyl oligopeptidase inhibition profile.EBI
University of Defense
Aromatic Esters of the Crinane Amaryllidaceae Alkaloid Ambelline as Selective Inhibitors of Butyrylcholinesterase.EBI
University of Defence
Novel Sustainable-by-Design HDAC Inhibitors for the Treatment of Alzheimer's Disease.EBI
University of Bras£Lia
New Dual Small Molecules for Alzheimer's Disease Therapy Combining Histamine HEBI
UBFC
Hydroxy-substituted trans-cinnamoyl derivatives as multifunctional tools in the context of Alzheimer's disease.EBI
Alma Mater Studiorum-University of Bologna